Free Trial

Ionis Pharmaceuticals (IONS) News Today

Ionis Pharmaceuticals logo
$33.32 +0.34 (+1.03%)
Closing price 04:00 PM Eastern
Extended Trading
$33.00 -0.32 (-0.96%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IONS Latest News

Ionis Pharmaceuticals, Inc. stock logo
Voloridge Investment Management LLC Sells 63,698 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Voloridge Investment Management LLC lessened its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 16.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 316,943 shares of the company's stock after selling 63,698 shares during th
Ionis Pharmaceuticals, Inc. stock logo
Woodline Partners LP Purchases New Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Woodline Partners LP purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 107,610 shares of the company's stoc
Ionis Pharmaceuticals, Inc. stock logo
D. E. Shaw & Co. Inc. Reduces Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
D. E. Shaw & Co. Inc. trimmed its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 84.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,123 shares of the company's st
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals (NASDAQ:IONS) Earns "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $50.00 target price on shares of Ionis Pharmaceuticals in a research report on Tuesday.
Ionis Pharmaceuticals, Inc. stock logo
Two Sigma Advisers LP Boosts Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Two Sigma Advisers LP grew its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 1.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,349,211 shares of the company's stock after purchas
Ionis Pharmaceuticals, Inc. stock logo
Millennium Management LLC Raises Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Millennium Management LLC lifted its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 79.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 774,215 shares of the company's stock after purchasing an additional 3
Ionis Pharmaceuticals, Inc. stock logo
Vestal Point Capital LP Acquires New Shares in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Vestal Point Capital LP acquired a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 595,000 shares of the company's stock, valued at approximately $20,801,0
Ionis Pharmaceuticals, Inc. stock logo
Tanaka Capital Management Inc. Decreases Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Tanaka Capital Management Inc. cut its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 52.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,892 shares of the company's stock after
Ionis Pharmaceuticals, Inc. stock logo
Tema Etfs LLC Purchases New Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Tema Etfs LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 56,844 shares of the company's stock, valued at approximately $
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Bought by Rafferty Asset Management LLC
Rafferty Asset Management LLC raised its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 19.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 237,337 shares of the company's stock after purchasing an
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Ensign Peak Advisors Inc
Ensign Peak Advisors Inc lessened its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 23.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 53,320 shares of the company's stock aft
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Holdings Boosted by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 63.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investo
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Holdings Raised by Orbimed Advisors LLC
Orbimed Advisors LLC grew its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 21.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,817,347 shares of the company's stock after acqui
Ionis Pharmaceuticals, Inc. stock logo
Jacobs Levy Equity Management Inc. Sells 368,966 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Jacobs Levy Equity Management Inc. lessened its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 56.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 281,813 shares of the company's stock after selling
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twenty brokerages that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendatio
Ionis Pharmaceuticals, Inc. stock logo
J. Goldman & Co LP Increases Stock Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
J. Goldman & Co LP raised its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 17.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 607,499 shares of the company's stock after buying
Ionis Pharmaceuticals, Inc. stock logo
Hudson Bay Capital Management LP Boosts Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Hudson Bay Capital Management LP grew its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 821,200 shares of the company's stock after buying an additional
Ionis Pharmaceuticals, Inc. stock logo
Northern Trust Corp Buys 97,367 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Northern Trust Corp increased its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 13.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 840,271 shares of the company's stock after pu
Ionis Pharmaceuticals, Inc. stock logo
Driehaus Capital Management LLC Sells 49,967 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Driehaus Capital Management LLC reduced its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 21.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1
Ionis Pharmaceuticals, Inc. stock logo
Caption Management LLC Sells 78,183 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Caption Management LLC decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 93.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,417 shares of the company's stock after selling 78,183 shares during the period
Ionis Pharmaceuticals, Inc. stock logo
Deep Track Capital LP Cuts Stock Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Deep Track Capital LP trimmed its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 12.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,933,928 shares
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Acquired by Bridgefront Capital LLC
Bridgefront Capital LLC boosted its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 94.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,802 shares of the company's stock after buying
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Alyeska Investment Group L.P.
Alyeska Investment Group L.P. trimmed its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 11.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 150,000 shares of
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company trimmed its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 7.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 286,279 shares of the company's sto
Ionis Pharmaceuticals, Inc. stock logo
Allostery Investments LP Invests $2.27 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Allostery Investments LP bought a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 65,000 shares of the company's stock, valued at
Ionis Pharmaceuticals, Inc. stock logo
BlueCrest Capital Management Ltd Buys Shares of 26,200 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
BlueCrest Capital Management Ltd purchased a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 26,200 shares of the company's stock, valued at approximately $916,0
Ionis Pharmaceuticals, Inc. stock logo
PDT Partners LLC Grows Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
PDT Partners LLC boosted its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 116.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,994 shares of the company's stock after purchasing an additional 15
Ionis Pharmaceuticals, Inc. stock logo
Schonfeld Strategic Advisors LLC Has $12.98 Million Stock Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Schonfeld Strategic Advisors LLC increased its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 371,381 shares of the co
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals (NASDAQ:IONS) Shares Gap Up on Earnings Beat
Ionis Pharmaceuticals (NASDAQ:IONS) Shares Gap Up After Strong Earnings
Ionis Pharmaceuticals, Inc. stock logo
Hsbc Holdings PLC Invests $2.93 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Hsbc Holdings PLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 83,055 shares of the company's stock, valued at approxi
Ionis Pharmaceuticals, Inc. stock logo
Tower Research Capital LLC TRC Increases Stock Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Tower Research Capital LLC TRC raised its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 229.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,157 shares of the company's sto
Ionis Pharmaceuticals, Inc. stock logo
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Purchased by Stifel Financial Corp
Stifel Financial Corp boosted its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 15.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 211,493 shares of the company's stock after buying an additional 28,98
Ionis Pharmaceuticals, Inc. stock logo
Susquehanna Fundamental Investments LLC Invests $7.45 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Susquehanna Fundamental Investments LLC bought a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 213,015 shares of the company's stock, value
Ionis Pharmaceuticals, Inc. stock logo
Adage Capital Partners GP L.L.C. Sells 225,000 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Adage Capital Partners GP L.L.C. lowered its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 45.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 275,000 shares of the company'
Ionis Pharmaceuticals, Inc. stock logo
Aquatic Capital Management LLC Makes New Investment in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Aquatic Capital Management LLC purchased a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 230,016 shares of the company's stock, valued at approximately $8,041,000. Aquati
Ionis Pharmaceuticals, Inc. stock logo
Price T Rowe Associates Inc. MD Decreases Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Price T Rowe Associates Inc. MD decreased its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 9.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,826,939 shares of the
Ionis Pharmaceuticals, Inc. stock logo
Raymond James Financial Inc. Purchases Shares of 105,619 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
Raymond James Financial Inc. purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 105,619 shares of the company's stock, valued at approximately $
Get Ionis Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter.

IONS Media Mentions By Week

IONS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IONS
News Sentiment

1.05

1.03

Average
Medical
News Sentiment

IONS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IONS Articles
This Week

10

8

IONS Articles
Average Week

Get Ionis Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IONS) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners